These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 31150699)

  • 1. Management of pediatric plaque psoriasis using biologics.
    Lansang P; Bergman JN; Fiorillo L; Joseph M; Lara-Corrales I; Marcoux D; McCuaig C; Pope E; Prajapati VH; Li SZJ; Landells I
    J Am Acad Dermatol; 2020 Jan; 82(1):213-221. PubMed ID: 31150699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologics and Psoriasis: The Beat Goes On.
    Kim HJ; Lebwohl MG
    Dermatol Clin; 2019 Jan; 37(1):29-36. PubMed ID: 30466686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric psoriasis: updates in biologic therapies.
    Sukhatme SV; Gottlieb AB
    Dermatol Ther; 2009; 22(1):34-9. PubMed ID: 19222515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of biologics in psoriasis.
    Kamata M; Tada Y
    J Dermatol; 2018 Mar; 45(3):279-286. PubMed ID: 29226369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologics in pediatric psoriasis - efficacy and safety.
    Dogra S; Mahajan R
    Expert Opin Drug Saf; 2018 Jan; 17(1):9-16. PubMed ID: 29022425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted therapies for pediatric psoriasis.
    Schwartz G; Paller AS
    Semin Cutan Med Surg; 2018 Sep; 37(3):167-172. PubMed ID: 30215634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolving role of biologics in the treatment of pediatric psoriasis.
    Luu M; Cordoro KM
    Skin Therapy Lett; 2013 Feb; 18(2):1-4. PubMed ID: 23508772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From conventional to cutting edge: the new era of biologics in treatment of psoriasis.
    Tzu J; Kerdel F
    Dermatol Ther; 2008; 21(2):131-41. PubMed ID: 18394087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis.
    Ovejero-Benito MC; Muñoz-Aceituno E; Reolid A; Saiz-Rodríguez M; Abad-Santos F; Daudén E
    Am J Clin Dermatol; 2018 Apr; 19(2):209-222. PubMed ID: 28921458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of biologic agents in pediatric psoriasis.
    Marji JS; Marcus R; Moennich J; Mackay-Wiggan J
    J Drugs Dermatol; 2010 Aug; 9(8):975-86. PubMed ID: 20684148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Management Guidelines for Moderate-to-Severe Plaque Psoriasis: A Review of Phototherapy, Systemic Therapies, and Biologic Agents.
    Ighani A; Partridge ACR; Shear NH; Lynde C; Gulliver WP; Sibbald C; Fleming P
    J Cutan Med Surg; 2019; 23(2):204-221. PubMed ID: 30463416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review.
    Maliyar K; Crowley EL; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ
    J Cutan Med Surg; 2019; 23(4):428-435. PubMed ID: 30938189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Data on the safety of psoriasis therapies.
    Leonardi CL
    Semin Cutan Med Surg; 2014 Jun; 33(4 Suppl):S73-5. PubMed ID: 25268600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of moderate-to-severe psoriasis: prescreening and monitoring psoriatic patients on biologics.
    Levine D; Strober BE
    Semin Cutan Med Surg; 2010 Mar; 29(1):28-34. PubMed ID: 20430305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential use of biologics in the treatment of moderate-to-severe plaque psoriasis.
    Leman J; Burden AD
    Br J Dermatol; 2012 Nov; 167 Suppl 3():12-20. PubMed ID: 23082811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psoriasis in the era of biologics].
    Torres T; Velho GC; Sanches M; Selores M
    Acta Med Port; 2010; 23(3):493-8. PubMed ID: 20654269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of safety and efficacy of approved systemic psoriasis therapies.
    Kaushik SB; Lebwohl MG
    Int J Dermatol; 2019 Jun; 58(6):649-658. PubMed ID: 30246393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do Biologics Protect Patients With Psoriasis From Myocardial Infarction? A Retrospective Cohort.
    Gulliver WP; Randell S; Gulliver S; Connors S; Bachelez H; MacDonald D; Gladney N; Morrissey A; Fleming P
    J Cutan Med Surg; 2016 Nov; 20(6):536-541. PubMed ID: 27207347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secukinumab for treating plaque psoriasis.
    Rothstein B; Gottlieb A
    Expert Opin Biol Ther; 2016; 16(1):119-28. PubMed ID: 26577956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of biologics in the treatment of moderate-to-severe plaque psoriasis.
    Puig L
    G Ital Dermatol Venereol; 2017 Feb; 152(1):28-35. PubMed ID: 27627100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.